Editorial
Copyright ©2009 The WJG Press and Baishideng. All rights reserved.
World J Gastroenterol. Jul 28, 2009; 15(28): 3457-3461
Published online Jul 28, 2009. doi: 10.3748/wjg.15.3457
Could quantitative liver function tests gain wide acceptance among hepatologists?
Giovanni Tarantino
Giovanni Tarantino, Department of Clinical and Experimental Medicine, Federico II University Medical School of Naples, 80131 Naples, Italy
Author contributions: Tarantino G wrote this editorial.
Correspondence to: Giovanni Tarantino, MD, Department of Clinical and Experimental Medicine, Federico II University Medical School of Naples, Via Sergio Pansini n. 5, 80131 Naples, Italy. tarantin@unina.it
Telephone: +39-81-7462024
Fax: +39-81-5466152
Received: June 12, 2009
Revised: July 9, 2009
Accepted: July 16, 2009
Published online: July 28, 2009
Abstract

It has been emphasized that the assessment of residual liver function is of paramount importance to determine the following: severity of acute or chronic liver diseases independent of etiology; long-term prognosis; step-by-step disease progression; surgical risk; and efficacy of antiviral treatment. The most frequently used tools are the galactose elimination capacity to asses hepatocyte cytosol activity, plasma clearance of indocyanine green to assess excretory function, and antipyrine clearance to estimate microsomal activity. However, a widely accepted liver test (not necessarily a laboratory one) to assess quantitative functional hepatic reserve still needs to be established, although there have been various proposals. Furthermore, who are the operators that should order these tests? Advances in analytic methods are expected to allow quantitative liver function tests to be used in clinical practice.

Keywords: Chronic diseases; Fatty liver; Hepatitis, viral; Liver cirrhosis; Liver function tests; Prognosis